Á¦1ȸ Çѱ¹°£¿Ü°ú¿¬±¸È¸ ¼¼¹Ì³ª : 2022-05-21±³À°ÀÏÀÚ : 2022-05-21
±³À°Àå¼Ò : ´ë¿õÁ¦¾à º£¾îȦ
±³À°ÁÖÁ¦ :
Á¦1ȸ Çѱ¹°£¿Ü°ú¿¬±¸È¸ ¼¼¹Ì³ªÁÖÃÖ±â°ü : Çѱ¹°£´ãÃé¿Ü°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Çѱ¹°£¿Ü°ú¿¬±¸È¸
´ã´çÀÚ : ±èÀºÈñ
¿¬¶ôó : 02-2135-2279
À̸ÞÀÏ :
office@thekalis.or.kr ±³À°Á¾·ù : ¿Ü°ú
Âü¼®¿¹»óÀοø : 50¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 15ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-21 º£¾î Ȧ 13:00~13:15 Indication setting for each approach for the beginner; Which approach should we use? ÇÑ¿µ¼®(°æºÏÀÇ´ë)
Åä·Ð 05-21 º£¾î Ȧ 13:15~13:30 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 05-21 º£¾î Ȧ 13:30~13:45 Each tip for glissonean pedicle approach in conventional and minimally invasive approach ±èÁöÈÆ(±¹¸³¾Ï¼¾ÅÍ)
Åä·Ð 05-21 º£¾î Ȧ 13:45~14:00 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 05-21 º£¾î Ȧ 14:00~14:15 The short-cut to shorten learning curve for liver surgery. ÇÑ´ëÈÆ(¿¬¼¼ÀÇ´ë)
Åä·Ð 05-21 º£¾î Ȧ 14:15~14:30 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 05-21 º£¾î Ȧ 14:30~15:00 Junior & Fellow ȸ¿ø ¼Ò°³ ÃÖ±âÈ«(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 05-21 º£¾î Ȧ 15:00~16:00 Video presentation ´Ù°»ç(´Ù¼Ò¼Ó)
ÈÞ½Ä 05-21 º£¾î Ȧ 16:00~16:10 ()
±³À°½Ã°£ 05-21 º£¾î Ȧ 16:10~16:30 Current status of liver diseases including HCC in Korea À¯¼öÁ¾(¼¿ïÀÇ´ë)
±³À°½Ã°£ 05-21 º£¾î Ȧ 16:30~16:45 Working definition of resectable HCC? ¹Ú¹Î¼ö(°æÈñÀÇ´ë)
±³À°½Ã°£ 05-21 º£¾î Ȧ 16:45~17:00 Recent updates of ablative therapies: RFA vs. MWA À̹οì(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 05-21 º£¾î Ȧ 17:00~17:15 TACE vs. Brigding TACE before Surgery ¹Ú¿µ¸ñ(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 05-21 º£¾î Ȧ 17:15~17:30 Initial LT vs. Salvage LT ÃÖ±Ô¼º(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 05-21 º£¾î Ȧ 17:30~17:45 Role of adjuvant therapies after initial treatment for HCC Á¶ÀºÁÖ(¼¿ïÀÇ´ë)
Åä·Ð 05-21 º£¾î Ȧ 17:45~18:00 Case discussion ÃÖ¿µ·Ï(¼¿ïÀÇ´ë)
Åä·Ð 05-21 º£¾î Ȧ 18:00~18:10 ÁúÀÇÀÀ´ä ()
±³À°½Ã°£ 05-21 º£¾î Ȧ 18:10~18:25 KOTUS-Liver ÀÚ·á ¼öÁý ÇöȲ ¹× °³¼±¹æ¾È ÀÌÇØ¿ø(¼¿ïÀÇ´ë)